Immunoregulatory Effect of Short-Chain Fatty Acids from Gut Microbiota on Obstructive Sleep Apnea-Associated Hypertension

References

• Zhang W, Si LY. Obstructive sleep apnea syndrome (OSAS) and hypertension: pathogenic mechanisms and possible therapeutic approaches. Ups J Med Sci. 2012;117:370–382. doi:10.3109/03009734.2012.707253
   PubMed Web of Science ®Google Scholar
• Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009;33:54–66. doi:10.1038/ijo.2008.229
   PubMed Web of Science ®Google Scholar
• Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1–7. doi:10.1016/j.phrs.2017.05.013
   PubMed Web of Science ®Google Scholar
• Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax. 2002;57:602–607. doi:10.1136/thorax.57.7.602
   PubMed Web of Science ®Google Scholar
• He Q, Feng J, Zhang X, et al. Relationship of daytime blood pressure and severity of obstructive sleep apnea among Chinese: a multi-center investigation in China. Chin Med J. 2010;123:18–22.
   PubMed Web of Science ®Google Scholar
• Hou H, Zhao Y, Yu W, et al. Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health. 2018;8:10405. doi:10.7189/jogh.08.010405
   PubMed Web of Science ®Google Scholar
• May AM, Van Wagoner DR, Mehra R. OSA and cardiac arrhythmogenesis: mechanistic insights. Chest. 2017;151:225–241. doi:10.1016/j.chest.2016.09.014
   PubMed Web of Science ®Google Scholar
• Pace A, Iannella G, Rossetti V, et al. Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis. Medicina. 2020;56. doi:10.3390/medicina56090454
   Web of Science ®Google Scholar
• Pollicina I, Maniaci A, Lechien JR, et al. Neurocognitive performance improvement after obstructive sleep apnea treatment: state of the art. Behav Sci. 2021;11. doi:10.3390/bs11120180
   PubMedGoogle Scholar
• Durgan DJ, Ganesh BP, Cope JL, et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertens (Dallas, Tex 1979). 2016;67:469–474. doi:10.1161/HYPERTENSIONAHA.115.06672
   PubMed Web of Science ®Google Scholar
• Bennett BJ, Vallim TQD, Wang ZN, et al. Trimethylamine-N-Oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17:49–60. doi:10.1016/j.cmet.2012.12.011
   PubMed Web of Science ®Google Scholar
• Martin-Gallausiaux C, Marinelli L, Blottière HM, Larraufie P, Lapaque N. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2020;80:37–49. doi:10.1017/S0029665120006916
   PubMed Web of Science ®Google Scholar
• Hang S, Paik D, Yao L, et al. Author correction: bile acid metabolites control T17 and T cell differentiation. Nature. 2020;579:E7. doi:10.1038/s41586-020-2030-5
   PubMed Web of Science ®Google Scholar
• Liu B, Qian J, Wang Q, Wang F, Ma Z, Qiao Y. Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion. PLoS One. 2014;9:e106184. doi:10.1371/journal.pone.0106184
   PubMed Web of Science ®Google Scholar
• Layden BT, Angueira AR, Brodsky M, Durai V, Lowe WLJ. Short chain fatty acids and their receptors: new metabolic targets. Transl Res. 2013;161:131–140. doi:10.1016/j.trsl.2012.10.007
   PubMed Web of Science ®Google Scholar
• Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A. Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease. Front Immunol. 2019;10:2754. doi:10.3389/fimmu.2019.02754
   PubMed Web of Science ®Google Scholar
• Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity. 2010;18:190–195. doi:10.1038/oby.2009.167
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359:1151–1156. doi:10.1126/science.aao5774
   PubMed Web of Science ®Google Scholar
• Rose S, Bennuri SC, Davis JE, et al. Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Transl Psychiatry. 2018;8:42. doi:10.1038/s41398-017-0089-z
   PubMed Web of Science ®Google Scholar
• Luu M, Visekruna A. Short-chain fatty acids: bacterial messengers modulating the immunometabolism of T cells. Eur J Immunol. 2019;49:842–848. doi:10.1002/eji.201848009
   PubMed Web of Science ®Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139:1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652
   PubMed Web of Science ®Google Scholar
• Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018;9:2247. doi:10.3389/fmicb.2018.02247
   PubMed Web of Science ®Google Scholar
• Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertens (Dallas, Tex 1979). 2015;65:1331–1340. doi:10.1161/HYPERTENSIONAHA.115.05315
   PubMed Web of Science ®Google Scholar
• Fu J, Bonder MJ, Cenit MC, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117:817–824. doi:10.1161/CIRCRESAHA.115.306807
   PubMed Web of Science ®Google Scholar
• Valles-Colomer M, Falony G, Darzi Y, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4:623–632. doi:10.1038/s41564-018-0337-x
   PubMed Web of Science ®Google Scholar
• Wang Q, Li F, Liang B, et al. A metagenome-wide association study of gut microbiota in asthma in UK adults. BMC Microbiol. 2018;18:114. doi:10.1186/s12866-018-1257-x
   PubMed Web of Science ®Google Scholar
• Tang WHW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183–1196. doi:10.1161/CIRCRESAHA.117.309715
   PubMed Web of Science ®Google Scholar
• Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. doi:10.1186/s40168-016-0222-x
   PubMed Web of Science ®Google Scholar
• Ko C-Y, Liu -Q-Q, Su H-Z, et al. Gut microbiota in obstructive sleep apnea-hypopnea syndrome: disease-related dysbiosis and metabolic comorbidities. Clin Sci. 2019;133:905–917. doi:10.1042/CS20180891
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59–65. doi:10.1038/nature08821
   PubMed Web of Science ®Google Scholar
• Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009;9:123. doi:10.1186/1471-2180-9-123
   PubMed Web of Science ®Google Scholar
• Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 2016;5:e73. doi:10.1038/cti.2016.17
   PubMed Web of Science ®Google Scholar
• Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8:80–93. doi:10.1038/mi.2014.44
   PubMed Web of Science ®Google Scholar
• Ko C-Y, Fan J-M, Hu A-K, et al. Disruption of sleep architecture in Prevotella enterotype of patients with obstructive sleep apnea-hypopnea syndrome. Brain Behav. 2019;9:e01287. doi:10.1002/brb3.1287
   PubMed Web of Science ®Google Scholar
• Valentini F, Evangelisti M, Arpinelli M, et al. Gut microbiota composition in children with obstructive sleep apnoea syndrome: a pilot study. Sleep Med. 2020;76:140–147. doi:10.1016/j.sleep.2020.10.017
   PubMed Web of Science ®Google Scholar
• Brahmakshatriya V, Kuang Y, Devarajan P, et al. IL-6 production by TLR-activated APC broadly enhances aged cognate CD4 Helper and B cell antibody responses in vivo. J Immunol. 2017;198:2819–2833. doi:10.4049/jimmunol.1601119
   PubMed Web of Science ®Google Scholar
• Zeng X, Guo R, Dong M, Zheng J, Lin H, Lu H. Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression. J Transl Med. 2018;16:106. doi:10.1186/s12967-018-1479-6
   PubMed Web of Science ®Google Scholar
• Schellekens DHSM, Grootjans J, Dello SAWG, et al. Plasma intestinal fatty acid-binding protein levels correlate with morphologic epithelial intestinal damage in a human translational ischemia-reperfusion model. J Clin Gastroenterol. 2014;48:253–260. doi:10.1097/MCG.0b013e3182a87e3e
   PubMed Web of Science ®Google Scholar
• Barceló A, Esquinas C, Robles J, et al. Gut epithelial barrier markers in patients with obstructive sleep apnea. Sleep Med. 2016;26:12–15. doi:10.1016/j.sleep.2016.01.019
   PubMed Web of Science ®Google Scholar
• Heizati M, Li N, Shao L, et al. Does increased serum d-lactate mean subclinical hyperpermeability of intestinal barrier in middle-aged nonobese males with OSA? Medicine (Baltimore). 2017;96:e9144. doi:10.1097/MD.0000000000009144
   PubMed Web of Science ®Google Scholar
• Natarajan N, Hori D, Flavahan S, et al. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics. 2016;48:826–834. doi:10.1152/physiolgenomics.00089.2016
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Miquel S, Noordine M-L, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. doi:10.1186/1741-7007-11-61
   PubMed Web of Science ®Google Scholar
• Raqib R, Sarker P, Bergman P, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A. 2006;103:9178–9183. doi:10.1073/pnas.0602888103
   PubMed Web of Science ®Google Scholar
• Raqib R, Sarker P, Mily A, et al. Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infect Dis. 2012;12:111. doi:10.1186/1471-2334-12-111
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543–547. doi:10.1038/nature09646
   PubMed Web of Science ®Google Scholar
• Sun L, Pan A, Yu Z, et al. Snoring, inflammatory markers, adipokines and metabolic syndrome in apparently healthy Chinese. PLoS One. 2011;6:e27515. doi:10.1371/journal.pone.0027515
   PubMed Web of Science ®Google Scholar
• Kheirandish-Gozal L, Peris E, Wang Y, et al. Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity. J Clin Endocrinol Metab. 2014;99:656–663. doi:10.1210/jc.2013-3327
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511. doi:10.1038/nri1391
   PubMed Web of Science ®Google Scholar
• Oyama J, Blais CJ, Liu X, et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004;109:784–789. doi:10.1161/01.CIR.0000112575.66565.84
   PubMed Web of Science ®Google Scholar
• Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–246. doi:10.1146/annurev-physiol-021909-135846
   PubMed Web of Science ®Google Scholar
• Kim CH, Park J, Kim M. Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw. 2014;14:277–288. doi:10.4110/in.2014.14.6.277
   PubMedGoogle Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34. doi:10.1038/nri.2015.5
   PubMed Web of Science ®Google Scholar
• Huuskonen J, Suuronen T, Nuutinen T, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. Br J Pharmacol. 2004;141:874–880. doi:10.1038/sj.bjp.0705682
   PubMed Web of Science ®Google Scholar
• Erny D, Hrabě de Angelis AL, Jaitin D, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18:965–977. doi:10.1038/nn.4030
   PubMed Web of Science ®Google Scholar
• Boyton RJ, Altmann DM. Is selection for TCR affinity a factor in cytokine polarization? Trends Immunol. 2002;23:526–529. doi:10.1016/s1471-4906(02)02319-0
   PubMed Web of Science ®Google Scholar
• Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178:6725–6729. doi:10.4049/jimmunol.178.11.6725
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Uyttenhove C, van Snick J, et al. Transforming growth factor-beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008;9:1341–1346. doi:10.1038/ni.1659
   PubMed Web of Science ®Google Scholar
• Bending D, De la Peña H, Veldhoen M, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest. 2009;119:565–572. doi:10.1172/JCI37865
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Tanaka K, Maeda Y, et al. Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells. Clin Exp Immunol. 2008;153:127–135. doi:10.1111/j.1365-2249.2008.03668.x
   PubMed Web of Science ®Google Scholar
• Atarashi K, Nishimura J, Shima T, et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808–812. doi:10.1038/nature07240
   PubMed Web of Science ®Google Scholar
• Zhou L, Lopes JE, Chong MMW, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453:236–240. doi:10.1038/nature06878
   PubMed Web of Science ®Google Scholar
• Maganto-García E, Bu D-X, Tarrio ML, et al. Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J Immunol. 2011;187:3521–3529. doi:10.4049/jimmunol.1003947
   PubMed Web of Science ®Google Scholar
• Foks AC, Frodermann V, Ter Borg M. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis. 2011;218:53–60. doi:10.1016/j.atherosclerosis.2011.04.029
   PubMed Web of Science ®Google Scholar
• van Es T, van Puijvelde GHM, Foks AC, et al. Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis. 2010;209:74–80. doi:10.1016/j.atherosclerosis.2009.08.041
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Cytokine network and T cell immunity in atherosclerosis. Semin Immunopathol. 2009;31:23–33. doi:10.1007/s00281-009-0143-x
   PubMed Web of Science ®Google Scholar
• Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther. 2013;38:804–816. doi:10.1111/apt.12453
   PubMed Web of Science ®Google Scholar
• Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189–200. doi:10.1080/19490976.2015.1134082
   PubMed Web of Science ®Google Scholar
• Sun M, Wu W, Chen L, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9:3555. doi:10.1038/s41467-018-05901-2
   PubMed Web of Science ®Google Scholar
• Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128–139. doi:10.1016/j.immuni.2013.12.007
   PubMed Web of Science ®Google Scholar
• Blad CC, Tang C, Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov. 2012;11:603–619. doi:10.1038/nrd3777
   PubMed Web of Science ®Google Scholar
• Candido EPM, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 1978;14:105–113. doi:10.1016/0092-8674(78)90305-7
   PubMed Web of Science ®Google Scholar
• Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell. 1978;14:115–121. doi:10.1016/0092-8674(78)90306-9
   PubMed Web of Science ®Google Scholar
• Asarat M, Apostolopoulos V, Vasiljevic T, Donkor O. Short-chain fatty acids regulate cytokines and Th17/Treg cells in human peripheral blood mononuclear cells in vitro. Immunol Invest. 2016;45:205–222. doi:10.3109/08820139.2015.1122613
   PubMed Web of Science ®Google Scholar
• Chen L, Sun M, Wu W, et al. Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells’ differentiation and function in induction of colitis. Inflamm Bowel Dis. 2019;25:1450–1461. doi:10.1093/ibd/izz046
   PubMed Web of Science ®Google Scholar
• Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003;133:2485S–2493S. doi:10.1093/jn/133.7.2485S
   PubMed Web of Science ®Google Scholar
• Moreno-Indias I, Torres M, Sanchez-Alcoholado L. Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur Respir J. 2015;45:1055–1065. doi:10.1183/09031936.00184314
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–180. doi:10.1038/nature09944
   PubMed Web of Science ®Google Scholar
• Durgan DJ. Obstructive sleep apnea-induced hypertension: role of the gut microbiota. Curr Hypertens Rep. 2017;19.doi: 10.1007/S11906-017-0732-3
   PubMed Web of Science ®Google Scholar
• Sapiña-Beltrán E, Santamaria-Martos F, Benítez I, et al. Normotensive patients with obstructive sleep apnoea: changes in 24-h ambulatory blood pressure monitoring with continuous positive airway pressure treatment. J Hypertens. 2019;37:720–727. doi:10.1097/HJH.0000000000001934
   PubMed Web of Science ®Google Scholar
• Binar M, Akcam T, Karakoc O, Sagkan RI, Musabak U, Gerek M. A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea? Eur Arch Oto-Rhino-L. 2017;274:829–836. doi:10.1007/s00405-016-4290-0
   PubMed Web of Science ®Google Scholar
• Maniaci A, Di Luca M, Lechien JR, et al. Lateral pharyngoplasty vs. traditional uvulopalatopharyngoplasty for patients with OSA: systematic review and meta-analysis. Sleep Breath. 2022. doi:10.1007/s11325-021-02520-y
   Web of Science ®Google Scholar
• Qian X, Yin T, Li T, et al. High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension. Inflammation. 2012;35:1507–1511. doi:10.1007/s10753-012-9464-3
   PubMed Web of Science ®Google Scholar
• Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci. 2005;1051:340–350. doi:10.1196/annals.1361.076
   PubMed Web of Science ®Google Scholar
• Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertens (Dallas, Tex 1979). 2009;54:619–624. doi:10.1161/HYPERTENSIONAHA.109.137158
   PubMed Web of Science ®Google Scholar
• Kassan M, Galan M, Partyka M, Trebak M, Matrougui K. Interleukin-10 released by CD4(+) CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol. 2011;31:2534–2542. doi:10.1161/ATVBAHA.111.233262
   PubMed Web of Science ®Google Scholar
• Oyama J-I, Node K. Gut microbiota and hypertension. Hypertens Res. 2019;42:741–743. doi:10.1038/s41440-018-0203-5
   PubMed Web of Science ®Google Scholar
• Mell B, Jala VR, Mathew AV. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics. 2015;47:187–197. doi:10.1152/physiolgenomics.00136.2014
   PubMed Web of Science ®Google Scholar
• Adnan S, Nelson JW, Ajami NJ, et al. Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics. 2017;49:96–104. doi:10.1152/physiolgenomics.00081.2016
   PubMed Web of Science ®Google Scholar
• Marques FZ, Nelson E, Chu P-Y, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135:964–977. doi:10.1161/CIRCULATIONAHA.116.024545
   PubMed Web of Science ®Google Scholar
• Toral M, Robles-Vera I, de la Visitación N, et al. Critical role of the interaction gut microbiota - sympathetic nervous system in the regulation of blood pressure. Front Physiol. 2019;10:231. doi:10.3389/fphys.2019.00231
   PubMed Web of Science ®Google Scholar
• Qi Y, Aranda JM, Rodriguez V, Raizada MK, Pepine CJ. Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - A case report. Int J Cardiol. 2015;201:157–158. doi:10.1016/j.ijcard.2015.07.078
   PubMed Web of Science ®Google Scholar
• Yellowlees Douglas J, Bhatwadekar AD, Li Calzi S, et al. Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy. Prog Retin Eye Res. 2012;31:481–494. doi:10.1016/j.preteyeres.2012.04.005
   PubMed Web of Science ®Google Scholar
• Ganesh BP, Nelson JW, Eskew JR, et al. Prebiotics, probiotics, and acetate supplementation prevent hypertension in a model of obstructive sleep apnea. Hypertension. 2018;72:1141–1150. doi:10.1161/HYPERTENSIONAHA.118.11695
   PubMed Web of Science ®Google Scholar
• Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110:4410–4415. doi:10.1073/pnas.1215927110
   PubMed Web of Science ®Google Scholar
• Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A. 2011;108:8030–8035. doi:10.1073/pnas.1016088108
   PubMed Web of Science ®Google Scholar
• Furness JB, Costa M. The adrenergic innervation of the gastrointestinal tract. Ergeb Physiol. 1974;69:2–51.
   PubMedGoogle Scholar
• Onyszkiewicz M, Gawrys-Kopczynska M, Konopelski P, et al. Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors. Pflugers Arch. 2019;471:1441–1453. doi:10.1007/s00424-019-02322-y
   PubMed Web of Science ®Google Scholar
• Poll BG, Xu J, Jun S, et al. Acetate, a short-chain fatty acid, acutely lowers heart rate and cardiac contractility along with blood pressure. J Pharmacol Exp Ther. 2021;377:39–50. doi:10.1124/jpet.120.000187
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin sleep cohort study. Wis Med J. 2009;108:246–249.
   Google Scholar
• Mashaqi S, Gozal D. Obstructive sleep apnea and systemic hypertension: gut dysbiosis as the mediator? J Clin Sleep Med. 2019;15:1517–1527. doi:10.5664/jcsm.7990
   PubMed Web of Science ®Google Scholar
• Ko C, Su H, Zhang L, Zeng Y. Disturbances of the gut microbiota, sleep architecture, and mTOR signaling pathway in patients with severe obstructive sleep apnea-associated hypertension. Int J Hypertens. 2021;2021:e43.
   Web of Science ®Google Scholar
• Campos-Rodriguez F, Asensio-Cruz MI, Cordero-Guevara J, et al. Effect of continuous positive airway pressure on inflammatory, antioxidant, and depression biomarkers in women with obstructive sleep apnea: a randomized controlled trial. Sleep. 2019;42. doi:10.1093/sleep/zsz145
   PubMed Web of Science ®Google Scholar
• Hall AB, Ziadi MC, Leech JA, et al. Effects of short-term continuous positive airway pressure on myocardial sympathetic nerve function and energetics in patients with heart failure and obstructive sleep apnea: a randomized study. Circulation. 2014;130:892–901. doi:10.1161/CIRCULATIONAHA.113.005893
   PubMed Web of Science ®Google Scholar
• Iftikhar IH, Valentine CW, Bittencourt LRA, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens. 2014;32:2341–50; discussion 2350. doi:10.1097/HJH.0000000000000372
   PubMed Web of Science ®Google Scholar
• Pengo MF, Ratneswaran C, Berry M, et al. Effect of continuous positive airway pressure on blood pressure variability in patients with obstructive sleep apnea. J Clin Hypertens. 2016;18:1180–1184. doi:10.1111/jch.12845
   Web of Science ®Google Scholar
• Perry RJ, Peng L, Barry NA, et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature. 2016;534:213–217. doi:10.1038/nature18309
   PubMed Web of Science ®Google Scholar
• De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65:1812–1821. doi:10.1136/gutjnl-2015-309957
   PubMed Web of Science ®Google Scholar
• Liu J, Li T, Wu H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4 + T cell induced-type I inflammation. Biomed Pharmacother. 2019;112:108580. doi:10.1016/j.biopha.2019.01.041
   PubMed Web of Science ®Google Scholar
• Robles-Vera I, Toral M, de la Visitación N, et al. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids. Mol Nutr Food Res. 2020;64:e1900616. doi:10.1002/mnfr.201900616
   PubMed Web of Science ®Google Scholar